Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT00100256
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2004
Completion: Apr 20, 2025